Design, synthesis, and biological evaluation of furan‐bearing pyrazolo[3,4‐b]pyridines as novel inhibitors of CDK2 and P53–MDM2 protein–protein interaction

Post time 2024-5-24 01:20:59

journal：Drug Development Research

Authors：Manal Abdel Fattah Ezzat; Ghada F. Elmasry; Menna M. A. Abd El‐Mageed; Marwa A. Fouad; Hatem A. Abdel‐Aziz; Safaa I. Elewa

Published date：2023-9-

DOI：10.1002/ddr.22079

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ddr.22079

Article link：http://dx.doi.org/10.1002/ddr.22079

Article Source：Wiley。

Remark：

Post time 2024-5-24 01:21:00

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] Design, synthesis, and biological evaluation of furan‐bearing pyrazolo[3,4‐b]pyridines as novel inhibitors of CDK2 and P53–MDM2 protein–protein interaction

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] Design, synthesis, and biological evaluation of furan‐bearing pyrazolo[3,4‐b]pyridines as novel inhibitors of CDK2 and P53–MDM2 protein–protein interaction Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Wiley] Design, synthesis, and biological evaluation of furan‐bearing pyrazolo[3,4‐b]pyridines as novel inhibitors of CDK2 and P53–MDM2 protein–protein interaction